Other Academic

Matthias Marti

Visiting Scientist

Immunology and Infectious Diseases

mmarti@hsph.harvard.edu


Bibliography

Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target.

Alam MM, Sanchez-Azqueta A, Janha O, Flannery EL, Mahindra A, Mapesa K, Char AB, Sriranganadane D, Brancucci NMB, Antonova-Koch Y, Crouch K, Simwela NV, Millar SB, Akinwale J, Mitcheson D, Solyakov L, Dudek K, Jones C, Zapatero C, Doerig C, Nwakanma DC, Vázquez MJ, Colmenarejo G, Lafuente-Monasterio MJ, Leon ML, Godoi PHC, Elkins JM, Waters AP, Jamieson AG, Álvaro EF, Ranford-Cartwright LC, Marti M, Winzeler EA, Gamo FJ, Tobin AB.

Science. 2019 08 30. 365(6456). PMID: 31467193


News

A cross-disciplinary approach to eradicating malaria

December 17, 2014 –There is an arsenal of cost-effective tools available to combat malaria but getting people to adhere to treatment regimens can be challenging, said Jessica Cohen, assistant professor of global health, at a symposium focused on…

Malaria parasite can hide in bone marrow

Parasites that transmit the deadliest form of malaria are able to hide in their host’s bone marrow during development. A research team led by Matthias Marti, associate professor of immunology and infectious diseases at Harvard School of Public…